Ceryvyn Therapeutics (CKDXF) Total Assets by Year
Ceryvyn Therapeutics Ltd closed fiscal year 2025 with $56.8M in total assets, $257.9M in total liabilities and -$201.1M in shareholder equity. Total assets fell 69.9% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Ceryvyn Therapeutics Ltd has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CKDXF Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F |
|---|---|---|---|---|---|---|---|
| Total Assets | $56.8M-69.9% | $188.8M+91.4% | $98.6M+64.3% | $60.0M-56.6% | $138.4M+180.0% | $49.4M+86.9% | $26.4M |
| Total Liabilities | $257.9M-2.5% | $264.6M+153.2% | $104.5M+765.8% | $12.1M+286.4% | $3.1M-35.8% | $4.9M+6.0% | $4.6M |
| Total Equity | -$201.1Mn/m | -$75.8Mn/m | -$5.9M-112.2% | $48.0M-64.5% | $135.3M+203.5% | $44.6M+104.0% | $21.9M |
CKDXF Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2420-F | Q4'2320-F | Q4'2220-F | Q2'226-K | Q4'2120-F | Q4'2020-F | Q4'1920-F |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $56.8M-69.9% | $188.8M+91.4% | $98.6M+64.3% | $60.0M-56.6% | $109.2M | $138.4M+180.0% | $49.4M+86.9% | $26.4M |
| Total Liabilities | $257.9M-2.5% | $264.6M+153.2% | $104.5M+765.8% | $12.1M+286.4% | $8.9M | $3.1M-35.8% | $4.9M+6.0% | $4.6M |
| Total Equity | -$201.1Mn/m | -$75.8Mn/m | -$5.9M-112.2% | $48.0M-64.5% | $100.3M | $135.3M+203.5% | $44.6M+104.0% | $21.9M |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Ceryvyn Therapeutics Ltd financials
Frequently Asked Questions
Ceryvyn Therapeutics Ltd closed fiscal year 2025 with $56.8M in total assets, $257.9M in total liabilities and -$201.1M in shareholder equity.
Ceryvyn Therapeutics Ltd (CKDXF) total assets fell by 69.9% year over year, from $188.8M to $56.8M in fiscal year 2025.
Across the 7 fiscal years this page covers, Ceryvyn Therapeutics Ltd (CKDXF) total assets went from $26.4M in fiscal year 2019 to $56.8M in fiscal year 2025.
Ceryvyn Therapeutics Ltd (CKDXF) reported $56.8M in total assets in Q4 2025. This represents a decrease of 69.9% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Ceryvyn Therapeutics Ltd (CKDXF) reported on that line in every period on record.